Biodegradable microneedles for transdermal sitagliptin delivery: in vivo insights into enhanced diabetes management. [PDF]
Yehia RM +5 more
europepmc +1 more source
ARD-101, a gut-restricted TAS2R agonist, reduces hunger in adults and promotes weight loss in DIO mice with DPP-4 inhibition. [PDF]
Zheng Z +10 more
europepmc +1 more source
Potential gonadal-beneficial effect of sitagliptin against paclitaxel-induced testicular dysfunction via mediating PERK/CHOP/NLRP3/Sestrin2 signaling pathway. [PDF]
El-Beheiry KM +3 more
europepmc +1 more source
The effect of empagliflozin on renal outcomes compared to sitagliptin with type 2 diabetes: target trial emulation using electronic medical records. [PDF]
Kang MJ +5 more
europepmc +1 more source
The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary Diseases. [PDF]
Panou T +2 more
europepmc +1 more source
Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma. [PDF]
Ramalingam PS +12 more
europepmc +1 more source
Improving glucose tolerance in obese rats: the role of Jinlida granules ( ) in gut microbiota modulation. [PDF]
Dongqi LI +12 more
europepmc +1 more source
Sustained-Release Sitagliptin Microneedles for Scar Prevention via Fibroblast-to-Adipocyte Conversion. [PDF]
Zhang JL +14 more
europepmc +1 more source
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial. [PDF]
Lim S +19 more
europepmc +1 more source
The mechanism study of targeting DPP4 in regulating ferroptosis and its influence on endometrial receptivity in PCOS. [PDF]
Zhang J +9 more
europepmc +1 more source

